Biotechnology Analyst

Alexander Chapman; New York (NY); On-site; USD 120,000 - 180,000; Full time

Job summary

Alexander Chapman is seeking an exceptional L/S Equity Analyst to join its investment team and invest across the Biotech sector. This is a highly selective opportunity to join a sophisticated investment platform where deep scientific expertise and differentiated fundamental research are central to the investment process.

You will have the opportunity to develop and express high conviction investment views across a complex and rapidly evolving sector.

Qualifications

• 2-3 years of L/S equity investing experience.
• MD or PhD from a leading institution.
• Demonstrated fundamental research and stock picking ability.
• Deep understanding of Biotech, drug development and key industry dynamics.

Responsibilities

• Develop and express high-conviction investment views across the Biotech sector.
• Invest across the Biotech sector as part of the investment team.
• Contribute to an investment platform where deep scientific expertise informs the research process.

Skills

L/S equity investing

Fundamental research

Stock picking

Biotech sector knowledge

Education

MD or PhD from leading institution

Job description

A highly regarded, specialist investment firm is hiring an exceptional L/S Equity Analyst to join its investment team and invest across the Biotech sector.

This is a highly selective opportunity to join a sophisticated investment platform where deep scientific expertise and differentiated fundamental research are central to the investment process.

You will have the opportunity to develop and express high conviction investment views across a complex and rapidly evolving sector.

The firm is seeking an investor who combines proven L/S investing experience with genuine scientific depth, ideally developed through an MD or PhD.

Requirements

• 2-3 years of L/S equity investing experience
• MD or PhD from a leading institution
• Demonstrated fundamental research and stock picking ability
• Deep understanding of Biotech, drug development and key industry dynamics